Skip to content
Trial Eligibility
Menu

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

NCT06552741

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) wants to screen people with alcohol and/or substance use disorders (ASUD) as well as people without ASUD for ongoing studies at NIDA in Baltimore, MD Objective: To screen people with or without ASUD for ongoing studies at NIDA.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Substance Use Disorder
  • Alcohol Use Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 99 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute on Drug Abuse (NIDA)
Last updated on ClinicalTrials.gov
August 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institute on Drug Abuse · Baltimore, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.